CHF-6001

Inhaled dual M3 antagonist/PDE4 inhibitor

intratracheal efficacy in model, not developed

from linking M3 antag. + PDE inh. and opt.

Journal of Medicinal Chemistry

Chiesi Farmaceutici S.p.A., Parma, IT

10. The Chiesi M3 antagonist/PDE4 inhibitor dual pharmacology molecule, compound 92a, is an inhaled compound intended for pulmonary diseases. Both M3 and PDE4 are clinically validated targets for COPD…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.